Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 25-36 of 992 results.
"We evaluated institutional risk factors associated with ventilator-associated pneumonia (VAP) and central line-associated bloodstream infection (CLABSI) rates" Besen et al (2025).
"Cefazolin elastomeric infusers are commonly used in outpatient settings with peripherally inserted central catheters (PICCs) or mid-line catheters to treat various infections. However, data on the safety of cefazolin elastomeric infusers administered via a peripheral IV catheter (PIVC) are limited" Chan et al (2025).
"To analyze the occurrence of anxiety and its influencing factors in stable stage breast cancer patients after chemotherapy with Implanted Venous Access Port (IVAP)" Wen et al (2025).
"Low birth weight (<1000 g) and non-central catheter tip location are significant predictors of PICC-related complications in neonates, while antimicrobial-impregnated catheters have a protective effect" Avsar et al (2025).
"The ANZ-MTR illustrates that complex and varied arrays of routinely collected clinical and hospital administrative data from multiple electronic information systems can be consolidated into a resource-rich clinical database" Sparrow et al (2025).
"We observed a pronounced variation in CLABSI rates between different catheter types. All episodes of CLABSI were observed after a dwell time of 5 days, with increasing rates after 9 days, and the rate of CLABSI increased with longer dwell times for UVCs and CVCs" Buttera et al (2025).
"In this nationwide study of Danish ICUs, antibiotic consumption decreased substantially over an 11-year period-driven by reductions in broad-spectrum classes-without evidence of worsening clinical outcomes" Meier et al (2025).
"The objectives of this blinded randomized controlled trial (RCT) were to assess the feasibility of conducting a definitive RCT of IN fentanyl for PICC placement in preterm infants and evaluate the acceptability and adoption of IN fentanyl for procedural pain management in the NICU" Tabbara et al (2025).
"This case report aims to highlight a rare but life-threatening complication of femoral venous catheterization and to describe a novel endovascular technique for its management" Li et al (2025).
"In conclusion, making minimal drug formulation concentration changes to an IV biologic formulation may reduce the risk, time commitment, and cost associated with developing a SC biologic formulation. Further education is needed around the transition of traditional IV formulations to low-concentration, large-volume SC formulations utilizing delivery formats such as an SC infusion pump or OBDS" Desai et al (2025).
"This review examines the epidemiology, risk factors, antifungal susceptibility, clinical manifestations, and mortality associated with C. auris, based on published literature from Saudi Arabia" Almajid et al (2025).
"This guideline summarizes evidence-based interventions for the management of extravasation of antineoplastic vesicants or irritants with vesicant properties to guide clinical care" Thomas et al (2025).
